Breast cancer screening is important for the early detection of breast canc
er. Tumors that become symptomatic in the screening interval are known as i
nterval cancers but the reasons for their rapid progression are unknown. Es
trogen receptor expression is lower in interval cancers suggesting that the
y may have reduced hormonal responsiveness. To investigate this hypothesis
we have measured the expression of the estrogen receptor and three estrogen
-responsive genes (cathepsin D, progesterone receptor, and TFF1) in screen-
detected and interval breast cancers. The expression of the protease cathep
sin D was not associated with estrogen receptor in either group of tumor. P
rogesterone receptor expression was highly correlated with that of the estr
ogen receptor in both groups of tumors but it was not expressed at signific
antly different levels in the two groups of tumors. Expression of TFF1, a c
ellular motogen, was correlated with estrogen receptor in screen-detected b
ut not interval cancers and was expressed at markedly higher levels in inte
rval breast tumors,the group that expresses Lower levels of estrogen recept
or. Interval cancers are characterized by high levels of expression of TFF1
and/or Ki67 suggesting that cell migration and cell division play importan
t roles in the rapid progression of interval cancers. The observation that
TFF1 expression in interval cancers tends to be estrogen-independent and th
at interval cancers have reduced estrogen receptor expression suggests they
may have a reduced response to hormone therapy.